StemLife is a Malaysia’s first integrated homegrown cord blood and adult stem cell banking and therapeutics company. Awarded MSC status in 2002 and Bionexus status in 2007, StemLife achieved MESDAQ listing in 2006 and has won several awards including the Technology Business Review Award and the Deloitte Technology Asia-Pacific Fast 500 Award.

Along with comprehensive stem cell banking services for babies and for adults, StemLife provides essential hematological and therapeutic services in collaboration with specialists and medical institutions, which has resulted in successful treatments of various diseases such as thalassaemia, chronic wounds and sports injuries.

StemLife is a founding member of the Asia Pacific Cord Blood Bank Consortium, an active participant in R&D projects and is ranked as one of the largest and most reputable companies in South East Asia.

www.StemLife.com